Best Practice & Research Clinical Gastroenterology
Volume 22, Issue 1 , Pages 3-15 , February 2008

New advances in pancreatic cell physiology and pathophysiology

  • Walter Halangk, PhD (Professor)

      Affiliations

    • Tel.: +49 3916 715 505; Fax: +49 3916 715 594
  • Markus M. Lerch, MD, FRCP (Professor of Medicine, Head)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 3834 867 230; Fax: +49 3834 867 234.

References 

  1. Wang BJ, Cui ZJ. How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R666–R678
  2. Gautam D, Han SJ, Heard TS, et al. Cholinergic stimulation of amylase secretion from pancreatic acinar cells studied with muscarinic acetylcholine receptor mutant mice. J Pharmacol Exp Therap. 2005 Jun;313(3):995–1002
  3. Sankaran H, Goldfine ID, Bailey A, et al. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Am J Physiol. 1982 Mar;242(3):G250–G257
  4. Sarri E, Ramos B, Salido GM, et al. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Br J Pharmacol. 2001 Aug;133(8):1227–1234
  5. Ji B, Bi Y, Simeone D, et al. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology. 2001 Dec;121(6):1380–1390
  6. Ji B, Bi Y, Simeone D, et al. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol Toxicol. 2002 Dec;91(6):327–332
  7. Galindo J, Jones N, Powell GL, et al. Advanced qRT-PCR technology allows detection of the cholecystokinin 1 receptor (CCK1R) expression in human pancreas. Pancreas. 2005 Nov;31(4):325–331
  8. Owyang C, Logsdon CD. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology. 2004 Sep;127(3):957–969
  9. Kawabata A, Kuroda R, Nishida M, et al. Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci. 2002 Oct 4;71(20):2435–2446
  10. Nguyen TD, Moody MW, Steinhoff M, et al. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest. 1999 Jan;103(2):261–269
  11. Sharma A, Tao X, Gopal A, et al. Protection against acute pancreatitis by activation of protease-activated receptor-2. Am J Physiol. 2005 Feb;288(2):G388–G395
  12. Singh VP, Bhagat L, Navina S, et al. Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut. 2007 Jul;56(7):958–964
  13. Sharma A, Tao X, Gopal A, et al. Calcium dependence of proteinase-activated receptor 2 and cholecystokinin-mediated amylase secretion from pancreatic acini. Am J Physiol. 2005 Oct;289(4):G686–G695
  14. Gerasimenko OV, Gerasimenko JV, Rizzuto RR, et al. The distribution of the endoplasmic reticulum in living pancreatic acinar cells. Cell Calcium. 2002 Nov–Dec;32(5–6):261–268
  15. Gerasimenko JV, Sherwood M, Tepikin AV, et al. NAADP, cADPR and IP3 all release Ca2+ from the endoplasmic reticulum and an acidic store in the secretory granule area. J Cell Sci. 2006 Jan 15;119(Pt 2):226–238
  16. Pickett JA, Thorn P, Edwardson JM. The plasma membrane Q-SNARE syntaxin 2 enters the zymogen granule membrane during exocytosis in the pancreatic acinar cell. J Biol Chem. 2005 Jan 14;280(2):1506–1511
  17. Wang CC, Ng CP, Lu L, et al. A role of VAMP8/endobrevin in regulated exocytosis of pancreatic acinar cells. Dev Cell. 2004 Sep;7(3):359–371
  18. Thorn P, Parker I. Two phases of zymogen granule lifetime in mouse pancreas: ghost granules linger after exocytosis of contents. J Physiol. 2005 Mar 1;563(Pt 2):433–442
  19. Muallem S, Kwiatkowska K, Xu X, et al. Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol. 1995 Feb;128(4):589–598
  20. Bi Y, Page SL, Williams JA. Rho and Rac promote acinar morphological changes, actin reorganization, and amylase secretion. Am J Physiol. 2005 Sep;289(3):G561–G570
  21. Bi Y, Williams JA. A role for Rho and Rac in secretagogue-induced amylase release by pancreatic acini. Am J Physiol Cell Physiol. 2005 Jul;289(1):C22–C32
  22. Torgerson RR, McNiven MA. The actin-myosin cytoskeleton mediates reversible agonist-induced membrane blebbing. J Cell Sci. 1998 Oct;111(Pt 19):2911–2922
  23. Lee M, Chung S, Uhm DY, et al. Regulation of zymogen granule exocytosis by Ca2+, cAMP, and PKC in pancreatic acinar cells. Biochem Biophys Res Commun. 2005 Sep 9;334(4):1241–1247
  24. Kruger B, Albrecht E, Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol. 2000 Jul;157(1):43–50
  25. Mooren F, Hlouschek V, Finkes T, et al. Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction. J Biol Chem. 2003 Mar 14;278(11):9361–9369
  26. Mooren FC, Turi S, Gunzel D, et al. Calcium-magnesium interactions in pancreatic acinar cells. Faseb J. 2001 Mar;15(3):659–672
  27. Husain SZ, Prasad P, Grant WM, et al. The ryanodine receptor mediates early zymogen activation in pancreatitis. Proceed Natl Acad Sci U S A. 2005 Oct 4;102(40):14386–14391
  28. Chaudhuri A, Kolodecik TR, Gorelick FS. Effects of increased intracellular cAMP on carbachol-stimulated zymogen activation, secretion, and injury in the pancreatic acinar cell. Am J Physiol. 2005 Feb;288(2):G235–G243
  29. Hofbauer B, Saluja AK, Lerch MM, et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol. 1998 Aug;275(2 Pt 1):G352–G362
  30. Kruger B, Lerch MM, Tessenow W. Direct detection of premature protease activation in living pancreatic acinar cells. Lab Invest J Tech Methods Pathol. 1998 Jun;78(6):763–764
  31. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. New Engl J Med. 1987 Jan 15;316(3):144–150
  32. Kukor Z, Mayerle J, Kruger B, et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem. 2002 Jun 14;277(24):21389–21396
  33. Halangk W, Lerch MM, Brandt-Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest. 2000 Sep;106(6):773–781
  34. Mahurkar S, Idris MM, Reddy DN, et al. Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut. 2006 Sep;55(9):1270–1275
  35. Weiss FU, Behn CO, Simon P, et al. Cathepsin B gene polymorphism Val26 is not associated with idiopathic chronic pancreatitis in Western patients. Gut. 2007;56(9):
  36. Lerch MM, Halangk W. Human pancreatitis and the role of cathepsin B. Gut. 2006 Sep;55(9):1228–1230
  37. Kuwata K, Hirota M, Shimizu H, et al. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol. 2002;37(11):928–934
  38. Masamune A, Kume K, Takagi Y, et al. N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas. 2007 May;34(4):423–428
  39. Ohmuraya M, Hirota M, Araki M, et al. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology. 2005 Aug;129(2):696–705
  40. Ohmuraya M, Hirota M, Araki K, et al. Enhanced trypsin activity in pancreatic acinar cells deficient for serine protease inhibitor kazal type 3. Pancreas. 2006 Jul;33(1):104–106
  41. Kiraly O, Wartmann T, Sahin-Toth M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut. 2007 May 24;
  42. Boulling A, Le Marechal C, Trouve P, et al. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet. 2007 Sep;15(9):936–942
  43. Kiraly O, Boulling A, Witt H, et al. Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat. 2007 May;28(5):469–476
  44. Weiss FU, Simon P, Witt H, et al. SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet. 2003 Apr;40(4):e40
  45. Archer H, Jura N, Keller J, et al. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology. 2006 Dec;131(6):1844–1855
  46. Selig L, Sack U, Gaiser S, et al. Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen. BMC Gastroenterol. 2006;6:30
  47. Simon P, Weiss FU, Sahin-Toth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem. 2002 Feb 15;277(7):5404–5410
  48. Teich N, Le Marechal C, Kukor Z, et al. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat. 2004 Jan;23(1):22–31
  49. Halangk W, Kruger B, Ruthenburger M, et al. Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation. Am J Physiol. 2002 Feb;282(2):G367–G374
  50. Rinderknecht H, Adham NF, Renner IG, et al. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion. Int J Pancreatol. 1988 Jan–Feb;3(1):33–44
  51. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996 Oct;14(2):141–145
  52. Kukor Z, Toth M, Sahin-Toth M. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur J Biochem/FEBS. 2003 May;270(9):2047–2058
  53. Sahin-Toth M, Toth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun. 2000 Nov 19;278(2):286–289
  54. Szmola R, Sahin-Toth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proceed Natl Acad Sci U S A. 2007 Jul 3;104(27):11227–11232
  55. Sherwood MW, Prior IA, Voronina SG, et al. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5674–5679
  56. Mareninova OA, Sung KF, Hong P, et al. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem. 2006 Feb 10;281(6):3370–3381
  57. Wang YL, Hu R, Lugea A, et al. Ethanol feeding alters death signaling in the pancreas. Pancreas. 2006 May;32(4):351–359
  58. Bhatia M, Wallig MA, Hofbauer B, et al. Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem Biophys Res Commun. 1998 May 19;246(2):476–483
  59. Cao Y, Adhikari S, Ang AD, et al. Crambene induces pancreatic acinar cell apoptosis via the activation of mitochondrial pathway. Am J Physiol. 2006 Jul;291(1):G95–G101
  60. Cao Y, Adhikari S, Clement MV, et al. Induction of apoptosis by crambene protects mice against acute pancreatitis via anti-inflammatory pathways. Am J Pathol. 2007 May;170(5):1521–1534

PII: S1521-6918(07)00123-0

doi: 10.1016/j.bpg.2007.10.017

Best Practice & Research Clinical Gastroenterology
Volume 22, Issue 1 , Pages 3-15 , February 2008

Article Tools